ATE214052T1 - 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-on- derivate mit pde iv-und cytokin-inhibisender aktivität - Google Patents

1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-on- derivate mit pde iv-und cytokin-inhibisender aktivität

Info

Publication number
ATE214052T1
ATE214052T1 AT96909150T AT96909150T ATE214052T1 AT E214052 T1 ATE214052 T1 AT E214052T1 AT 96909150 T AT96909150 T AT 96909150T AT 96909150 T AT96909150 T AT 96909150T AT E214052 T1 ATE214052 T1 AT E214052T1
Authority
AT
Austria
Prior art keywords
pde
phenylalkyl
dihydro
imidazole
derivatives
Prior art date
Application number
AT96909150T
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Gaston Stanislas Marcell Diels
Gil Jose Ignacio Andres
Gadea Francisco Javi Fernandez
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE214052T1 publication Critical patent/ATE214052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96909150T 1995-04-06 1996-03-28 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-on- derivate mit pde iv-und cytokin-inhibisender aktivität ATE214052T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200868 1995-04-06
EP95202898 1995-10-26
PCT/EP1996/001394 WO1996031485A1 (en) 1995-04-06 1996-03-28 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity

Publications (1)

Publication Number Publication Date
ATE214052T1 true ATE214052T1 (de) 2002-03-15

Family

ID=26139205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909150T ATE214052T1 (de) 1995-04-06 1996-03-28 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-on- derivate mit pde iv-und cytokin-inhibisender aktivität

Country Status (26)

Country Link
US (2) US5994376A (de)
EP (1) EP0819122B1 (de)
JP (1) JP4562101B2 (de)
KR (1) KR100406628B1 (de)
CN (1) CN1068591C (de)
AR (1) AR002732A1 (de)
AT (1) ATE214052T1 (de)
AU (1) AU702947B2 (de)
CA (1) CA2216653C (de)
CY (1) CY2328B1 (de)
CZ (1) CZ293127B6 (de)
DE (1) DE69619661T2 (de)
DK (1) DK0819122T3 (de)
ES (1) ES2174064T3 (de)
HR (1) HRP960155A2 (de)
HU (1) HU223324B1 (de)
IL (1) IL117807A (de)
MX (1) MX9707652A (de)
MY (1) MY119254A (de)
NO (1) NO314339B1 (de)
NZ (1) NZ304877A (de)
PL (1) PL187375B1 (de)
PT (1) PT819122E (de)
SI (1) SI0819122T1 (de)
TW (1) TW332201B (de)
WO (1) WO1996031485A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703098A (en) * 1994-12-30 1997-12-30 Celgene Corporation Immunotherapeutic imides/amides
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
ATE236884T1 (de) * 1996-10-02 2003-04-15 Janssen Pharmaceutica Nv Pde-iv hemmende 2-cyanoiminoimidazol-derivate
BR9811499A (pt) 1997-07-10 2000-09-19 Janssen Pharmaceutica Nv "derivados da 6-azauracila como inibidores da il-5"
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
JP4778612B2 (ja) * 1998-04-01 2011-09-21 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｐｄｅｉｖ阻害ピリジン誘導体
US6118017A (en) * 1998-04-14 2000-09-12 Smithkline Beecham Corporation Substituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-one
CA2328250A1 (en) * 1998-04-14 1999-10-21 Smithkline Beecham Corporation Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
CA2352503C (en) 1998-11-23 2009-04-07 Janssen Pharmaceutica N.V. Il-5 inhibiting 6-azauracil derivatives
TR200101729T2 (tr) 1998-12-18 2001-10-22 Janssen Pharmaceutica N.V. IL-5 engelleyici 6-azaurasil türevleri
US6916810B2 (en) 2000-09-13 2005-07-12 Merck & Co., Inc. αν integrin receptor antagonists
WO2002094321A1 (en) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions for promoting healing of bone fracture
KR20040007583A (ko) 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 연골 질환의 재생치료용 조성물
US6706739B2 (en) * 2001-08-21 2004-03-16 National Health Research Institute Imidazolidinone compounds
SE0200667D0 (sv) * 2002-03-05 2002-03-05 A & Science Invest Ab Novel use of cytokine inhibitors
GB0326407D0 (en) * 2003-11-12 2003-12-17 Glaxo Group Ltd Chemical compounds
GB0412865D0 (en) * 2004-06-09 2004-07-14 Glaxo Group Ltd Chemical compounds
JP4657297B2 (ja) * 2004-07-05 2011-03-23 ドン ファ ファーマシューティカル カンパニー リミテッド アレルギー性炎症疾患の予防及び治療用組成物
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
JP2009525269A (ja) * 2006-01-30 2009-07-09 ユーロ−セルティーク エス．エイ． カルシウムチャネルブロッカーとしての環状尿素化合物
EP1834953A1 (de) 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyran-Derivate als 5-Lipoxygenase-Hemmer
US7390772B2 (en) * 2006-05-18 2008-06-24 International Flavor & Fragrances Inc. 1-phenyl-spiro[2.5]octane-1-carbonitrile analogues their use in fragrance formulations
US8450481B2 (en) * 2007-06-14 2013-05-28 The Regents Of The University Of California Compounds for inhibiting protein aggregation, and methods for making and using them
NZ601967A (en) * 2010-03-12 2015-03-27 Omeros Corp Pde10 inhibitors and related compositions and methods
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
NZ630810A (en) 2014-04-28 2016-03-31 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
CA2980801A1 (en) 2015-04-24 2016-10-27 Omeros Corporation Pde10 inhibitors and related compositions and methods
CA3003611C (en) 2015-11-04 2022-11-01 Omeros Corporation Solid state forms of a pde10 inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL285394A (de) * 1961-11-17
US3184060A (en) 1963-02-13 1965-05-18 Owens Illinois Glass Co Packaging tacky latex emulsion paints in containers manufactured from polyolefinic maerials
KR930703262A (ko) * 1990-11-06 1993-11-29 스튜어트 알. 슈터 이미다졸리디논 화합물
DK0672031T3 (da) * 1992-12-02 2003-06-10 Pfizer Catecholdiethere som selektive PDE IV-inhibitorer
TW263495B (de) * 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives

Also Published As

Publication number Publication date
CA2216653A1 (en) 1996-10-10
PL187375B1 (pl) 2004-06-30
HK1007880A1 (en) 1999-04-30
JP4562101B2 (ja) 2010-10-13
NZ304877A (en) 1999-06-29
SI0819122T1 (en) 2002-06-30
HRP960155A2 (en) 1997-10-31
PL322654A1 (en) 1998-02-16
CN1068591C (zh) 2001-07-18
PT819122E (pt) 2002-08-30
KR19980703449A (ko) 1998-11-05
ES2174064T3 (es) 2002-11-01
US20020068830A1 (en) 2002-06-06
EP0819122A1 (de) 1998-01-21
CY2328B1 (en) 2004-02-06
CA2216653C (en) 2009-05-26
HUP9801575A2 (hu) 1999-01-28
HU223324B1 (hu) 2004-06-28
US5994376A (en) 1999-11-30
AU5275596A (en) 1996-10-23
NO314339B1 (no) 2003-03-10
AR002732A1 (es) 1998-04-29
IL117807A (en) 2001-06-14
CZ314997A3 (cs) 1998-12-16
HUP9801575A3 (en) 1999-03-01
TW332201B (en) 1998-05-21
US6403805B1 (en) 2002-06-11
IL117807A0 (en) 1996-08-04
MX9707652A (es) 1997-11-29
NO974602L (no) 1997-10-06
CN1181072A (zh) 1998-05-06
DE69619661D1 (de) 2002-04-11
KR100406628B1 (ko) 2004-05-31
EP0819122B1 (de) 2002-03-06
DK0819122T3 (da) 2002-07-01
NO974602D0 (no) 1997-10-06
AU702947B2 (en) 1999-03-11
MY119254A (en) 2005-04-30
WO1996031485A1 (en) 1996-10-10
JPH11503136A (ja) 1999-03-23
DE69619661T2 (de) 2002-10-31
CZ293127B6 (cs) 2004-02-18

Similar Documents

Publication Publication Date Title
NO974602D0 (no) 1,3-Dihydro-1-(fenylalkyl)-2H-imidazol-2-onderivater med PDE IV- og cytokinaktivitet
NL350016I2 (nl) 3-aryl-4-hydroxy-delta#3-dihydrofuranon-en 3-aryl-4-hydroxy-delta#3-dihydrothiofenon-derivaten.
NO944421D0 (no) Substituerte 1,2,3,4-tetrahydroisokinoliner med angiotensin II reseptoraktivitet
EG19187A (en) Quinazoline derivatives and their use as fungicide.
DE68929361D1 (de) Oligoribonukleotid-Derivate und Verwendung davon als Antiviral Arzneimittel
FI943618L (fi) Uudet amidiinijohdannaiset, niiden valmistus ja käyttö lääkeaineina, joilla on LTB4-antagonistinen vaikutus
DE69728608D1 (de) Benzimidazol-Derivate mit antihistaminischer Wirkung
FI970502L (fi) Makrofagiperäinen kemokiini ja kemokiinijohdannaisia
FI942310L (fi) 1,3-substituoidut sykloalkeenit ja sykloalkaanit keskushermostoon vaikuttavina aineina
DE3869167D1 (de) Phenyltriazol-derivate und insectizid.
NO905485D0 (no) Benzazepin- og benzotiazepin-derivater.
DE69424051D1 (de) Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität
AU703235B2 (en) 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity
EP0858456A4 (de) Triterpen-derivate mit immunosuppressiver aktivität
FI933544A7 (fi) Tiadiatsiinikarboksamidijohdannaiset, menetelmät niiden valmistamiseks i ja lääkkeet
ATE305455T1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
FI934221A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI951996A7 (fi) 4-kinolinyylijohdannaiset, joilla on Helicobakteerin vastaista aktiivisuutta
FI934665L (fi) Aryliden-1-azacykloalkaner och arylalkyl-1-azacyckloalkaner, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning och framstaellning
DE69203699D1 (de) Arylindazolderivate und ihre Verwendung.
GB2257139B (en) Maltooligoside derivative, and its use for determining alpha-amylase activity
PT101252A (pt) Derivados de piridona-azetidinilo substituidos com actividade antimicrobiana
NO981939D0 (no) Tiomorfinaner med neurobeskyttende aktivitet
ITMI922071A0 (it) Derivati xantonici, loro preparazione ed attivita'
ZA929394B (en) Piperidine derivatives, their preparation and use.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification